Related Experiment Video
Updated: Mar 31, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
The Association Between Genetic Polymorphism in the Receptor for Advanced Glycation End-Products and Metabolic
Nourhan Mohammed1, Mona M Hassouna1, Mohammed S Mostafa1
1Clinical Pathology Department, National Liver Institute, Menoufia University, Shebein El-Kom, Egypt.
Background/Aims:
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a liver manifestation of metabolic syndrome; its prevalence is increasing, especially in developed countries. Around 20% of individuals diagnosed with MASLD progress to metabolic dysfunction-associated steatohepatitis (MASH). Owing to the liver's role in the removal and breakdown of circulating advanced glycosylation end-products (AGEs), AGEs and the receptor for AGEs (RAGE) might be involved in MASLD development and progression. This study aimed to assess the effect of RAGE gene polymorphism (rs1800624) on the development of MASLD and MASH.
Methods:
This study was conducted on 30 MASH patients compared to 30 MASLD patients collected from the outpatient clinic at the National Liver Institute and 30 age- and gender-matched healthy controls. Genotyping of the RAGE gene (rs1800624) was performed by the real-time polymerase chain reaction technique.
Results:
Patients with MASH had a higher incidence of diabetes and hypertension and a higher body mass index compared to those with MASLD. Genotyping of the RAGE gene (rs1800624) showed that the A allele frequency was higher among MASH patients compared to controls, with the AA genotype carrying a greater risk for MASH development compared to the (AT + TT) genotypes.
Conclusion:
The RAGE rs1800624 polymorphism may be associated with an increased risk of MASH development.
More Related Videos
Related Concept Videos
Inborn Errors of Metabolism
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Drug toxicity: Idiosyncratic Reactions
Proteoglycans

